Literature DB >> 10912466

Role of Ca2+- and swelling-activated Cl- channels in alpha1-adrenoceptor-mediated tone in pressurized rabbit mesenteric arterioles.

C V Remillard1, M A Lupien, V Crépeau, N Leblanc.   

Abstract

BACKGROUND: Ca2+-activated (I(Cl(Ca))) and swelling-induced (I(Cl(swell))) Cl- channels have, respectively, been postulated to participate in the membrane depolarization and contraction mediated by activation of alpha1-adrenoceptors and vascular wall distension during pressurization. Their respective function in generating active force in pressurized arterioles during alpha1-adrenoceptor stimulation remains unsettled.
OBJECTIVES: Experimental protocols were designed to: (1) assess the relative contribution of I(Cl(Ca)) to the pressure-dependence of lumen diameter of mesenteric arterioles at different states of activation of the alpha1-adrenoceptor, and (2) investigate the potential role of I(Cl(swell)) in spontaneous and agonist-mediated myogenic reactivity.
METHODS: Segments of endothelium-denuded rabbit mesenteric arterioles with a lumen diameter of approximately 70 microm were cannulated at both ends and studied under isobaric conditions at 36 degrees C. Steady-state lumen diameter at each pressure step investigated (0-100 mmHg, in 20-mmHg increments) was measured by a video-microscopy edge-detection technique.
RESULTS: Under control conditions, 23% of the arterioles developed nifedipine-sensitive spontaneous myogenic tone. In the presence of 1 mM tetraethylammonium chloride (TEA) to inhibit Ca2+-dependent K+ channels, the alpha1-agonist phenylephrine (PE) contracted the vessels in a concentration-dependent manner (0.1-10 microM) and potentiated myogenic reactivity. The contraction mediated by 1 microM PE/TEA was abolished by 1 microM nifedipine, indicating that Ca2+ entry through voltage-gated Ca2+ channels was a necessary step in the cascade leading to contraction. Niflumic acid (NfA, 100 microM), a relatively selective inhibitor of I(Cl(Ca)), had no effect on myogenic tone but reversed the PE-induced contraction, varying with the concentration of PE and transmural pressure. For PE concentrations between 0.1 and 1 microM, but not for 10 microM PE, the relaxing efficacy of NfA decreased as applied pressure was raised from 0 to 100 mmHg. At all pressure steps, the NfA-induced relaxation was inversely related to the concentration of PE. DIDS (200 microM), another Cl- channel blocker, inhibited spontaneous myogenic tone, and partially suppressed a component of contraction at elevated transmural pressures in arterioles incubated in 1 microM PE/1 mM TEA/100 microM NfA.
CONCLUSIONS: Our data indicate that under low to moderate stimulation of the alpha1-adrenoceptor signaling pathway, I(Cl(Ca)) channels play an important role in the sustained contraction produced. Their declining contribution to contraction with increasing transmural pressure may be explained, at least in part, by a progressive enhancement of stretch-induced ionic conductances, possibly volume-sensitive Cl- channels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10912466     DOI: 10.1016/s0008-6363(00)00021-3

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  12 in total

1.  Differential regulation of Ca(2+)-activated Cl(-) currents in rabbit arterial and portal vein smooth muscle cells by Ca(2+)-calmodulin-dependent kinase.

Authors:  I A Greenwood; J Ledoux; N Leblanc
Journal:  J Physiol       Date:  2001-07-15       Impact factor: 5.182

Review 2.  The ClC-3 chloride channels in cardiovascular disease.

Authors:  Dayue Darrel Duan
Journal:  Acta Pharmacol Sin       Date:  2011-05-23       Impact factor: 6.150

3.  Increased TMEM16A-encoded calcium-activated chloride channel activity is associated with pulmonary hypertension.

Authors:  Abigail S Forrest; Talia C Joyce; Marissa L Huebner; Ramon J Ayon; Michael Wiwchar; John Joyce; Natalie Freitas; Alison J Davis; Linda Ye; Dayue D Duan; Cherie A Singer; Maria L Valencik; Iain A Greenwood; Normand Leblanc
Journal:  Am J Physiol Cell Physiol       Date:  2012-10-03       Impact factor: 4.249

4.  Phosphorylation alters the pharmacology of Ca(2+)-activated Cl channels in rabbit pulmonary arterial smooth muscle cells.

Authors:  M Wiwchar; R Ayon; I A Greenwood; N Leblanc
Journal:  Br J Pharmacol       Date:  2009-09-28       Impact factor: 8.739

5.  Modulation of Ca2+-dependent Cl- channels by calcineurin in rabbit coronary arterial myocytes.

Authors:  Jonathan Ledoux; Iain Greenwood; Louis R Villeneuve; Normand Leblanc
Journal:  J Physiol       Date:  2003-08-22       Impact factor: 5.182

6.  Aging and muscle fiber type alter K+ channel contributions to the myogenic response in skeletal muscle arterioles.

Authors:  Lori S Kang; SeJeong Kim; James M Dominguez; Amy L Sindler; Gregory M Dick; Judy M Muller-Delp
Journal:  J Appl Physiol (1985)       Date:  2009-04-30

Review 7.  Antenatal hypoxia and pulmonary vascular function and remodeling.

Authors:  Demosthenes G Papamatheakis; Arlin B Blood; Joon H Kim; Sean M Wilson
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

8.  Effects of chloride channel blockers on hypotonicity-induced contractions of the rat trachea.

Authors:  Roberta R Coelho; Emmanuel P Souza; Pedro M G Soares; Ana Vaneska P Meireles; Geam C M Santos; Henrique C Scarparo; Ana Maria S Assreuy; David N Criddle
Journal:  Br J Pharmacol       Date:  2003-12-22       Impact factor: 8.739

Review 9.  Molecular and functional significance of Ca(2+)-activated Cl(-) channels in pulmonary arterial smooth muscle.

Authors:  Normand Leblanc; Abigail S Forrest; Ramon J Ayon; Michael Wiwchar; Jeff E Angermann; Harry A T Pritchard; Cherie A Singer; Maria L Valencik; Fiona Britton; Iain A Greenwood
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

10.  PI3K and PKC contribute to membrane depolarization mediated by alpha2-adrenoceptors in the canine isolated mesenteric vein.

Authors:  Ilia A Yamboliev; Violeta N Mutafova-Yambolieva
Journal:  BMC Physiol       Date:  2005-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.